News

The FDA cleared the investigational new drug application of IDE849, a potential first-in-class DLL3-targeted antibody-drug ...
Lupin's approved tablets, indicated for the treatment of HIV-1 infection, are bioequivalent to Merck Sharp & Dohme LLC’s ...
New Delhi: Through a recent notice, the Central Drugs Standard Control Organisation (CDSCO) has issued revised guidance ...
Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has ...
Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product ...
We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to ...
IASO Biotherapeutics ('IASO Bio'), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...
Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...
CDSCO revises guidelines for issuance of export NOC for unapproved, approved new drugs: Gireesh Babu, New Delhi Friday, May 9, 2025, 08:00 Hrs [IST] The Central Drugs Standard Con ...
Cranston, Rhode Island – Nelipak Corp., a leading global provider of healthcare packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, ...
Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma CRANBERRY TOWNSHIP, PENNSYLVANIA / ACCESS Newswire / May 9, 2025 / Jabez Biosc ...
The University of Portsmouth is hosting a thought-provoking evening event all about how new technology can improve healthcare ...